{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreieltsuaf5xqkn2gbqtykqsf5b7dxame2hmn4qmjk4spuhpqvijg5u",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mnihynymqyi2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreidtimd3jvpnwd6oboba256rmvtwfgwxtmi2tgua7k5gx2psxrdxta"
    },
    "mimeType": "image/jpeg",
    "size": 143927
  },
  "path": "/news/2026-06-drug-relapse-rare-immune-disorder.html",
  "publishedAt": "2026-06-04T15:20:07.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Stanford Medicine researchers and their colleagues found that a new drug, obexelimab, significantly reduces the risk of relapse in patients with IgG4-related disease, a rare chronic immune condition often misdiagnosed as cancer.",
  "title": "New drug cuts relapse risk by half in rare immune disorder trial"
}